Prelude Therapeutics, Inc. (PRLD)

2.78 +0.51 (+22.47%) USD  |  NASDAQ  |  Feb 20, 16:00
2.82 +0.04 (+1.44%) Pre-Market: 08:51
More

Prelude Therapeutics Long Term Deferred Tax Liabilities (Quarterly)

Long Term Deferred Tax Liabilities (Quarterly) Chart

View Long Term Deferred Tax Liabilities (Quarterly) for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Liabilities (Quarterly) Benchmarks

View Long Term Deferred Tax Liabilities (Quarterly) Benchmarks
Start Trial
BioLife Solutions, Inc. Upgrade
Immunome, Inc. --
Incyte Corp. Upgrade
Aclaris Therapeutics, Inc. --
Relay Therapeutics, Inc. --